AbbVie Inc. (ABBV) vs Oracle Corporation (ORCL)
See how AbbVie Inc. and Oracle Corporation differ across market data and performance, so you can decide which asset best fits your strategy.
$256.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page$149.12
NYSE
Oracle Corporation delivers enterprise applications and infrastructure solutions through flexible IT deployment models, including on-premises, cloud, and hybrid environments. Founded in 1977, Oracle introduced the first commercial SQL-based relational database management system, widely used by many of the world’s largest enterprises for high-volume online transaction processing. In addition to its database products, Oracle offers enterprise resource planning platforms and cloud infrastructure that are becoming increasingly important for large language model training and inference.
View Full PageKey Metrics Comparison
AbbVie Inc.ABBV
Market Cap$453.124B
Price$256.42
24h Change+0.37%
24h Volume$4.24M
Employees57,000
Shares Outstanding1,768,169,012
Oracle CorporationORCL
Market Cap$429.536B
Price$149.12
24h Change-1.15%
24h Volume$15.66M
Employees162,000
Shares Outstanding2,876,046,000
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ABBV
51.3%ORCL
48.7%Volume Share
Share of combined 24h volume
ABBV
21.3%ORCL
78.7%24h Performance
Price change over last 24 hours
ABBV
0.37%ORCL
-1.15%Price Comparison
AbbVie Inc.
Oracle Corporation